| comm, commun | communicable |
|---|---|
| Med | Tech medical technology, medical technologist |
| DOC | 1) Drug Of Choice 2) Diagnosis Of Choice 3) De-Oxy-Cortist... |
| WPW Syndrome | Wolff-Parkinson-White Syndrome ? CIx 1. Drugs; AV Conduct... |
| DOC | date of conception; deoxycholate; deoxycorticosterone; died of other causes; disorders of cornificat... |
| DOC | 11-Deoxycorticosterone |
|---|---|
| 18-OH-DOC | 18-Hydroxy-11-deoxycorticosterone |
| 18-OH-DOC | 18-hydroxy-deoxycorticosterone |
| 19-nor-DOC | 19-Nor-deoxycorticosterone |
| DOC | AB-deoxycholate |
| vena-tech ivc filter | <radiology> Introduced as LGM (L.G. Medical, France), 1985; FDA aprroval 1991: Vena-Tech, Evanston, IL, 6-leg conical design with 6 stabilizing side bars, biocompatible metal known as Phynox (cobalt,chromium,iron,nickel,moly) Efficacy, recurrent PE: 2-6%, IVC occlusion: 8-24%, migration: 0-12% Advantages, ease of placement, excellent clot trapping efficiency, low profile, lacks ferromagnetic activity: minimal MRI artifacts Disadvantages, incomplete opening (6-19%): decreases clot-trapping efficiency, increased incidence from IJ approach, decreased with rapid deployment, increased IVC thrombosis rates: 8% initial reports; 22-24% on subsequent reports by ultrasound/MRI: 2-19% clinically symptomatic (12 Dec 1998) |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|